SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 409 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $41,821 | -95.7% | 345 | -95.9% | 0.00% | -100.0% |
| Q2 2023 | $967,465 | +69451.8% | 8,448 | -16.3% | 0.01% | -36.4% |
| Q1 2023 | $1,391 | +2682.0% | 10,095 | +2522.1% | 0.01% | – |
| Q4 2022 | $50 | -99.9% | 385 | 0.0% | 0.00% | – |
| Q3 2022 | $43,000 | +7.5% | 385 | -28.7% | 0.00% | – |
| Q2 2022 | $40,000 | -42.9% | 540 | -39.3% | 0.00% | – |
| Q1 2022 | $70,000 | -56.2% | 890 | -60.1% | 0.00% | -100.0% |
| Q4 2021 | $160,000 | -43.9% | 2,231 | -27.6% | 0.00% | -50.0% |
| Q3 2021 | $285,000 | -9.5% | 3,081 | -23.9% | 0.00% | 0.0% |
| Q2 2021 | $315,000 | -22.4% | 4,047 | -25.7% | 0.00% | -33.3% |
| Q1 2021 | $406,000 | -62.0% | 5,447 | -13.2% | 0.00% | -57.1% |
| Q4 2020 | $1,069,000 | +59.8% | 6,272 | +31.7% | 0.01% | +40.0% |
| Q3 2020 | $669,000 | -40.3% | 4,761 | -31.9% | 0.01% | -50.0% |
| Q2 2020 | $1,120,000 | +167.9% | 6,988 | +63.7% | 0.01% | +100.0% |
| Q1 2020 | $418,000 | +166.2% | 4,270 | +250.0% | 0.01% | +400.0% |
| Q4 2019 | $157,000 | -21.1% | 1,220 | -53.9% | 0.00% | -50.0% |
| Q3 2019 | $199,000 | -1.0% | 2,645 | +99.6% | 0.00% | 0.0% |
| Q2 2019 | $201,000 | +40.6% | 1,325 | +10.4% | 0.00% | +100.0% |
| Q1 2019 | $143,000 | -57.9% | 1,200 | -61.5% | 0.00% | -75.0% |
| Q4 2018 | $340,000 | -16.3% | 3,116 | +23.8% | 0.00% | 0.0% |
| Q3 2018 | $406,000 | +1930.0% | 2,516 | +814.9% | 0.00% | – |
| Q1 2018 | $20,000 | -28.6% | 275 | -45.0% | 0.00% | – |
| Q4 2017 | $28,000 | +21.7% | 500 | 0.0% | 0.00% | – |
| Q3 2017 | $23,000 | +35.3% | 500 | 0.0% | 0.00% | – |
| Q2 2017 | $17,000 | +88.9% | 500 | +56.2% | 0.00% | – |
| Q1 2017 | $9,000 | -43.8% | 320 | -46.7% | 0.00% | – |
| Q4 2016 | $16,000 | – | 600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
| Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
| Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
| Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
| Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
| Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
| ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
| Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
| Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
| GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |